Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of MZ-1866, a gene therapy for Pitt Hopkins Syndrome
Grant Award Details
Grant Type:
Grant Number:
CLIN2-19119
Investigator(s):
Award Value:
$8,000,000
Status:
Pre-Active
Grant Application Details
Application Title: